BACKGROUND: Breast cancer survival disparities by race are likely multifactorial. In a small pilot cohort, we demonstrated a statistical interaction between age and race. The purpose of this study was to validate earlier findings in a larger, more diverse cohort and to test the hypothesis that breast cancer survival is influenced by the dependent relationship of age and race. METHODS: We conducted a retrospective analysis of a multi-institutional breast cancer database for patients treated between 1999 and 2009. Study variables included age and disease stage at diagnosis, race, treatment (surgery, chemotherapy, radiotherapy, hormone therapy) and overall survival. Statistical analysis and regression models were performed by Stata software. RESULTS: A total of 9,249 patients were included in this study. African American, Hispanic, and Asian patients were more likely to present at a younger age with metastases. African American and Hispanic race were associated with increased mortality after adjusting for stage, age, and treatment. A 2-way interaction between age and race was identified in the Cox regression model (p < 0.001). To further define this interaction, a postestimation analysis was performed to determine the predicted relative hazard for each race with age fixed at 40, 50, 60, 70, and 80 years. At younger ages, the predicted relative hazard was significantly higher for both African American and Hispanic race. CONCLUSIONS: Despite adjusting for stage and treatment differences, African American and Hispanic race predicted poor survival. The effect of age and treatment on breast cancer survival differs across races. Additional research is needed to accurately determine the reasons for worsened survival.
BACKGROUND:Breast cancer survival disparities by race are likely multifactorial. In a small pilot cohort, we demonstrated a statistical interaction between age and race. The purpose of this study was to validate earlier findings in a larger, more diverse cohort and to test the hypothesis that breast cancer survival is influenced by the dependent relationship of age and race. METHODS: We conducted a retrospective analysis of a multi-institutional breast cancer database for patients treated between 1999 and 2009. Study variables included age and disease stage at diagnosis, race, treatment (surgery, chemotherapy, radiotherapy, hormone therapy) and overall survival. Statistical analysis and regression models were performed by Stata software. RESULTS: A total of 9,249 patients were included in this study. African American, Hispanic, and Asian patients were more likely to present at a younger age with metastases. African American and Hispanic race were associated with increased mortality after adjusting for stage, age, and treatment. A 2-way interaction between age and race was identified in the Cox regression model (p < 0.001). To further define this interaction, a postestimation analysis was performed to determine the predicted relative hazard for each race with age fixed at 40, 50, 60, 70, and 80 years. At younger ages, the predicted relative hazard was significantly higher for both African American and Hispanic race. CONCLUSIONS: Despite adjusting for stage and treatment differences, African American and Hispanic race predicted poor survival. The effect of age and treatment on breast cancer survival differs across races. Additional research is needed to accurately determine the reasons for worsened survival.
Authors: Kristin Wallace; Allan DeToma; David N Lewin; Shaoli Sun; Don Rockey; Carolyn D Britten; Jennifer D Wu; Aissatou Ba; Anthony J Alberg; Elizabeth G Hill Journal: Clin Colorectal Cancer Date: 2016-12-07 Impact factor: 4.481
Authors: Amy E Ustjanauskas; Gwendolyn P Quinn; Tonya M Pan; Maria Rivera; Coralia Vázquez-Otero; Danielle Ung; Richard G Roetzheim; Christine Laronga; Kenneth Johnson; Marilyn Norton; Claudia Carrizosa; Dariana Muñoz; Marissa Goldenstein; Sumayah Nuhaily; Kristen J Wells Journal: J Cancer Educ Date: 2017-12 Impact factor: 2.037
Authors: Yamilé Molina; Catherine M Pichardo; Donald L Patrick; Scott D Ramsey; Sonia Bishop; Shirley A A Beresford; Gloria D Coronado Journal: J Health Dispar Res Pract Date: 2018
Authors: Bridget A Oppong; Angel A Rolle; Amara Ndumele; Yaming Li; James L Fisher; Oindrila Bhattacharyya; Toyin Adeyanju; Electra D Paskett Journal: Breast Cancer Res Treat Date: 2022-09-24 Impact factor: 4.624
Authors: Zhiyang Liu; Zeyad Sahli; Yongchun Wang; Antonio C Wolff; Leslie M Cope; Christopher B Umbricht Journal: Breast Cancer Res Treat Date: 2018-09-17 Impact factor: 4.872
Authors: Clement G Yedjou; Jennifer N Sims; Lucio Miele; Felicite Noubissi; Leroy Lowe; Duber D Fonseca; Richard A Alo; Marinelle Payton; Paul B Tchounwou Journal: Adv Exp Med Biol Date: 2019 Impact factor: 2.622